关于 "c-MET" 的结果6 个结果

筛选:Other Apoptosis×

GC11733
PHA-665752
CAS: 477575-56-7
A selective c-Met inhibitor
Other Apoptosis
GC11089
SU11274
CAS: 658084-23-2
A potent, selective inhibitor of c-Met
Autophagy
GC13598
MGCD-265
CAS: 875337-44-3
A c-Met and VEGFR2 inhibitor
Other Apoptosis
GC14256
Tivantinib (ARQ 197)
CAS: 905854-02-6
An inhibitor of c-Met
Other Apoptosis
GC17866
INCB28060
CAS: 1029712-80-8
INCB28060是一种高效、口服生物利用度高的c-Met抑制剂，其IC₅₀值为0.13nM。INCB28060用于治疗成人转移性非小细胞肺癌（NSCLC），包括Met外显子14跳跃产生的突变变体的NSCLC患者。
Other Apoptosis
GC33189
SAR125844
CAS: 1116743-46-4
SAR125844 is a potent intravenously active and highly selective Met (c-Met) kinase inhibitor, displaying nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and H1094Y, Y1235D, M1250T, L1195V, and D1228H kinase domain mutants (IC50 values of 0.22, 1.7, 6.5, 65, and 81 nmol/L, respectively).
Other Apoptosis

搜索结果产品列表
货号	产品名称	CAS号	靶点 / 通路
GC11733	PHA-665752	477575-56-7	Other Apoptosis
GC11733	A selective c-Met inhibitor
GC11089	SU11274	658084-23-2	Autophagy
GC11089	A potent, selective inhibitor of c-Met
GC13598	MGCD-265	875337-44-3	Other Apoptosis
GC13598	A c-Met and VEGFR2 inhibitor
GC14256	Tivantinib (ARQ 197)	905854-02-6	Other Apoptosis
GC14256	An inhibitor of c-Met
GC17866	INCB28060	1029712-80-8	Other Apoptosis
GC17866	INCB28060是一种高效、口服生物利用度高的c-Met抑制剂，其IC₅₀值为0.13nM。INCB28060用于治疗成人转移性非小细胞肺癌（NSCLC），包括Met外显子14跳跃产生的突变变体的NSCLC患者。
GC33189	SAR125844	1116743-46-4	Other Apoptosis
GC33189	SAR125844 is a potent intravenously active and highly selective Met (c-Met) kinase inhibitor, displaying nanomolar activity against the wild-type kinase (IC50 value of 4.2 nmol/L) and H1094Y, Y1235D, M1250T, L1195V, and D1228H kinase domain mutants (IC50 values of 0.22, 1.7, 6.5, 65, and 81 nmol/L, respectively).